CliffBio
small molecule

TPOXX

TECOVIRIMAT

Loss of exclusivitySeptember 2031latest FDA-listed patent expiry
CompanySIGA Technologies →View the full company profile on CliffBio

Drug detail

Brand nameTPOXX
Active ingredientTECOVIRIMAT
Strength200MG/20ML (10MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMay 2022
Marketing statusRX

Listed patents

PatentExpiresType
7737168September 2031use U-3377
9907859August 2031use U-3377
10576165August 2031product
9233097August 2031product
8039504July 2027product

More from SIGA Technologies

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TPOXX patent cliff — loss of exclusivity September 2031 | CliffBio